The scarcity of proteogenomic research on lung adenocarcinoma in never smokers without EGFR or ALK mutations has resulted in an oversimplified view of these diseases, treating them collectively as a single, homogeneous, yet undefined entity. The gene discussed is EGFR; the disease is lung adenocarcinoma.